{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T13:35:39Z","timestamp":1794576939744,"version":"4.9.1"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.critrevonc.2024.104552","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T06:42:19Z","timestamp":1731048139000},"page":"104552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["The role of amino acid PET in radiotherapy target volume delineation for adult-type diffuse gliomas: A review of the literature"],"prefix":"10.1016","volume":"205","author":[{"given":"Patrick J.","family":"Horsley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale L.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Schembri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Drummond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Back","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.critrevonc.2024.104552_bib1","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/neuonc\/now058","article-title":"Response assessment in neuro-oncology working group and European association for neuro-oncology recommendations for the clinical use of PET imaging in gliomas","volume":"18","author":"Albert","year":"2016","journal-title":"Neuro Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104552_bib2","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00259-015-3276-2","article-title":"Early static (18)F-FET-PET scans have a higher accuracy for glioma grading than the standard 20\u201340\u2009min scans","volume":"43","author":"Albert","year":"2016","journal-title":"Eur. J. Nucl. Med Mol. Imaging"},{"issue":"7","key":"10.1016\/j.critrevonc.2024.104552_bib3","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.2967\/jnumed.111.097881","article-title":"Accurate differentiation of recurrent gliomas from radiation injury by kinetic analysis of alpha-11C-methyl-L-tryptophan PET","volume":"53","author":"Alkonyi","year":"2012","journal-title":"J. Nucl. Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104552_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15010098","article-title":"Hotspot on 18F-FET PET\/CT to Predict Aggressive Tumor Areas for Radiotherapy Dose Escalation Guiding in High-Grade Glioma","volume":"15","author":"Allard","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.critrevonc.2024.104552_bib5","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/neuonc\/noz166","article-title":"Recurrent glioblastoma versus late posttreatment changes: diagnostic accuracy of O-(2-[18F]fluoroethyl)-L-tyrosine positron emission tomography (18F-FET PET)","volume":"21","author":"Bashir","year":"2019","journal-title":"Neuro Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104552_bib6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1515\/JPM.2000.008","article-title":"Relation between brain tissue pO2 and dopamine synthesis of basal ganglia--a 18FDOPA-PET study in newborn piglets","volume":"28","author":"Bauer","year":"2000","journal-title":"J. Perinat. Med"},{"issue":"11","key":"10.1016\/j.critrevonc.2024.104552_bib7","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s00259-003-1259-1","article-title":"Brain tumour imaging with PET: a comparison between [18F]fluorodopa and [11C]methionine","volume":"30","author":"Becherer","year":"2003","journal-title":"Eur. J. Nucl. Med Mol. Imaging"},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104552_bib8","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/00004728-198703000-00002","article-title":"PET study of methionine accumulation in glioma and normal brain tissue: competition with branched chain amino acids","volume":"11","author":"Bergstrom","year":"1987","journal-title":"J. Comput. Assist Tomogr."},{"issue":"7","key":"10.1016\/j.critrevonc.2024.104552_bib9","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/s00259-003-1205-2","article-title":"3-O-methyl-6-[18F]fluoro-L-DOPA and its evaluation in brain tumour imaging","volume":"30","author":"Beuthien-Baumann","year":"2003","journal-title":"Eur. J. Nucl. Med Mol. Imaging"},{"key":"10.1016\/j.critrevonc.2024.104552_bib10","article-title":"Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12)","volume":"45","author":"Bodensohn","year":"2024","journal-title":"Clin. Transl. Radiat. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104552_bib11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11060-015-1970-3","article-title":"Tryptophan PET predicts spatial and temporal patterns of post-treatment glioblastoma progression detected by contrast-enhanced MRI","volume":"126","author":"Bosnyak","year":"2016","journal-title":"J. Neurooncol"},{"key":"10.1016\/j.critrevonc.2024.104552_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1306164","article-title":"The MANGO study: a prospective investigation of oxygen enhanced and blood-oxygen level dependent MRI as imaging biomarkers of hypoxia in glioblastoma","volume":"13","author":"Brighi","year":"2023","journal-title":"Front Oncol."},{"issue":"14","key":"10.1016\/j.critrevonc.2024.104552_bib13","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1056\/NEJMoa1500925","article-title":"Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma","volume":"374","author":"Buckner","year":"2016","journal-title":"N. Engl. J. Med"},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104552_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13051063","article-title":"Advanced Imaging Techniques for Radiotherapy Planning of Gliomas","volume":"13","author":"Castellano","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104552_bib15","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ijrobp.2006.12.009","article-title":"Evaluation of peritumoral edema in the delineation of radiotherapy clinical target volumes for glioblastoma","volume":"68","author":"Chang","year":"2007","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"issue":"8","key":"10.1016\/j.critrevonc.2024.104552_bib16","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa1308345","article-title":"Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma","volume":"370","author":"Chinot","year":"2014","journal-title":"N. Engl. J. Med"},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104552_bib17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s13566-013-0132-5","article-title":"Tryptophan PET-defined gross tumor volume offers better coverage of initial progression than standard MRI-based planning in glioblastoma patients","volume":"3","author":"Christensen","year":"2014","journal-title":"J. Radiat. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104552_bib18","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/ana.410440603","article-title":"Imaging epileptogenic tubers in children with tuberous sclerosis complex using alpha-[11C]methyl-L-tryptophan positron emission tomography","volume":"44","author":"Chugani","year":"1998","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104552_bib19","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1470-2045(21)00090-5","article-title":"Adjuvant and concurrent temozolomide for 1p\/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study","volume":"22","author":"van den Bent","year":"2021","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104552_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/jcbfm.1990.1","article-title":"A new method to measure brain serotonin synthesis in vivo. I. Theory and basic data for a biological model","volume":"10","author":"Diksic","year":"1990","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.critrevonc.2024.104552_bib21","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.radonc.2020.06.025","article-title":"Radiotherapy target volume definition in newly diagnosed high grade glioma using 18F-FET PET imaging and multiparametric perfusion MRI: A prospective study (IMAGG)","volume":"150","author":"Dissaux","year":"2020","journal-title":"Radio. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104552_bib22","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/jech.52.6.377","article-title":"The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions","volume":"52","author":"Downs","year":"1998","journal-title":"J. Epidemiol. Community Health"},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104552_bib23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/01.rmr.0000245464.36148.dc","article-title":"Contrast-enhanced magnetic resonance imaging of central nervous system tumors: agents, mechanisms, and applications","volume":"17","author":"Essig","year":"2006","journal-title":"Top. Magn. Reson Imaging"},{"key":"10.1016\/j.critrevonc.2024.104552_bib24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.radonc.2019.12.005","article-title":"Margin reduction in radiotherapy for glioblastoma through 18F-fluoroethyltyrosine PET? - A recurrence pattern analysis","volume":"145","author":"Fleischmann","year":"2020","journal-title":"Radiother. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104552_bib25","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00259-014-2959-4","article-title":"Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-L-tyrosine PET","volume":"42","author":"Galldiks","year":"2015","journal-title":"Eur. J. Nucl. Med Mol. Imaging"},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104552_bib26","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.ijrobp.2010.07.002","article-title":"An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases","volume":"81","author":"Grosu","year":"2011","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104552_bib27","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijrobp.2005.01.045","article-title":"L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy","volume":"63","author":"Grosu","year":"2005","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104552_bib28","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.radonc.2016.06.004","article-title":"Pre-irradiation tumour volumes defined by MRI and dual time-point FET-PET for the prediction of glioblastoma multiforme recurrence: A prospective study","volume":"120","author":"Harat","year":"2016","journal-title":"Radio. Oncol."},{"issue":"JAN) (pagination","key":"10.1016\/j.critrevonc.2024.104552_bib29","article-title":"Relationship between glioblastoma dose volume parameters measured by dual time point Fluoroethylthyrosine-PET and clinical outcomes","volume":"8","author":"Harat","year":"2018","journal-title":"Front. Neurol."},{"issue":"7","key":"10.1016\/j.critrevonc.2024.104552_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16071265","article-title":"A Biopsy-Controlled Prospective Study of Contrast-Enhancing Diffuse Glioma Infiltration Based on FET-PET and FLAIR","volume":"16","author":"Harat","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104552_bib31","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1038\/s41467-023-39731-8","article-title":"Combining amino acid PET and MRI imaging increases accuracy to define malignant areas in adult glioma","volume":"14","author":"Harat","year":"2023","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104552_bib32","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.prro.2018.01.006","article-title":"Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastoma","volume":"8","author":"Hayes","year":"2018","journal-title":"Pract. Radiat. Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2024.104552_bib33","first-page":"1367","article-title":"Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo","volume":"40","author":"Heiss","year":"1999","journal-title":"J. Nucl. Med"},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104552_bib34","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3171\/2018.4.JNS1859","article-title":"11C-methionine-18F-FDG dual-PET-tracer-based target delineation of malignant glioma: evaluation of its geometrical and clinical features for planning radiation therapy","volume":"131","author":"Hirata","year":"2019","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.critrevonc.2024.104552_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110386","article-title":"FET PET-based target volume delineation for the radiotherapy of glioblastoma: A pictorial guide to help overcome methodological pitfalls","volume":"198","author":"Holzgreve","year":"2024","journal-title":"Radiother. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104552_bib36","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ijrobp.2015.04.044","article-title":"Methionine Uptake and Required Radiation Dose to Control Glioblastoma","volume":"93","author":"Iuchi","year":"2015","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104552_bib37","first-page":"432","article-title":"Radiolabeled amino acids: basic aspects and clinical applications in oncology","volume":"42","author":"Jager","year":"2001","journal-title":"J. Nucl. Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104552_bib38","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40644-015-0045-1","article-title":"Multi-modal imaging of tumor cellularity and Tryptophan metabolism in human Gliomas","volume":"15","author":"Jeong","year":"2015","journal-title":"Cancer Imaging"},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104552_bib39","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/neuonc\/noy169","article-title":"Multimodal imaging-defined subregions in newly diagnosed glioblastoma: impact on overall survival","volume":"21","author":"John","year":"2019","journal-title":"Neuro Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2024.104552_bib40","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1097\/RLU.0b013e318251e458","article-title":"Quantitative PET imaging of tryptophan accumulation in gliomas and remote cortex: correlation with tumor proliferative activity","volume":"37","author":"Juhasz","year":"2012","journal-title":"Clin. Nucl. Med"},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104552_bib41","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1212\/01.WNL.0000049468.05050.F2","article-title":"Alpha-methyl-L-tryptophan PET detects epileptogenic cortex in children with intractable epilepsy","volume":"60","author":"Juhasz","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.critrevonc.2024.104552_bib42","doi-asserted-by":"crossref","DOI":"10.2310\/7290.2014.00015","article-title":"Comparison of amino acid positron emission tomographic radiotracers for molecular imaging of primary and metastatic brain tumors","volume":"13","author":"Juhasz","year":"2014","journal-title":"Mol. Imaging"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104552_bib43","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11060-013-1043-4","article-title":"Tryptophan PET in pretreatment delineation of newly-diagnosed gliomas: MRI and histopathologic correlates","volume":"112","author":"Kamson","year":"2013","journal-title":"J. Neurooncol"},{"issue":"10","key":"10.1016\/j.critrevonc.2024.104552_bib44","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/neuonc\/nou042","article-title":"Increased tryptophan uptake on PET has strong independent prognostic value in patients with a previously treated high-grade glioma","volume":"16","author":"Kamson","year":"2014","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.critrevonc.2024.104552_bib45","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.phro.2018.06.004","article-title":"Dosimetric impact of amino acid positron emission tomography imaging for target delineation in radiation treatment planning for high-grade gliomas","volume":"6","author":"Kazda","year":"2018","journal-title":"Phys. Imaging Radiat. Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2024.104552_bib46","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-071327","article-title":"[(18)F]-fluoroethyl-L-tyrosine (FET) in glioblastoma (FIG) TROG 18.06 study: protocol for a prospective, multicentre PET\/CT trial","volume":"13","author":"Koh","year":"2023","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104552_bib47","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11060-019-03152-9","article-title":"NRG brain tumor specialists consensus guidelines for glioblastoma contouring","volume":"143","author":"Kruser","year":"2019","journal-title":"J. Neurooncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104552_bib48","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.ijrobp.2021.03.032","article-title":"Initial Results of a Phase 2 Trial of 18F-DOPA PET-Guided Dose-Escalated Radiation Therapy for Glioblastoma","volume":"110","author":"Laack","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104552_bib49","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1186\/s12885-024-12469-2","article-title":"(11)C-methionine in the diagnostics and management of glioblastoma patients with rapid early progression: nonrandomized, open label, prospective clinical trial (GlioMET)","volume":"24","author":"Lakomy","year":"2024","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104552_bib50","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.nucmedbio.2006.01.002","article-title":"O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications","volume":"33","author":"Langen","year":"2006","journal-title":"Nucl. Med Biol."},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104552_bib51","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00259-001-0716-y","article-title":"Fluorinated amino acids for tumour imaging with positron emission tomography","volume":"29","author":"Laverman","year":"2002","journal-title":"Eur. J. Nucl. Med Mol. Imaging"},{"issue":"7","key":"10.1016\/j.critrevonc.2024.104552_bib52","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.7326\/M22-0276","article-title":"QUAPAS: An Adaptation of the QUADAS-2 Tool to Assess Prognostic Accuracy Studies","volume":"175","author":"Lee","year":"2022","journal-title":"Ann. Intern Med"},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104552_bib53","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ijrobp.2008.04.050","article-title":"Association of 11C-methionine PET uptake with site of failure after concurrent temozolomide and radiation for primary glioblastoma multiforme","volume":"73","author":"Lee","year":"2009","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104552_bib54","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1007\/s00259-020-04706-0","article-title":"Spatial and quantitative mapping of glycolysis and hypoxia in glioblastoma as a predictor of radiotherapy response and sites of relapse","volume":"47","author":"Leimgruber","year":"2020","journal-title":"Eur. J. Nucl. Med Mol. Imaging"},{"issue":"8","key":"10.1016\/j.critrevonc.2024.104552_bib55","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104552_bib56","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.radonc.2017.01.002","article-title":"Patterns of failure for patients with glioblastoma following O-(2-[18F]fluoroethyl)-L-tyrosine PET- and MRI-guided radiotherapy","volume":"122","author":"Lundemann","year":"2017","journal-title":"Radio. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104552_bib57","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijrobp.2010.09.020","article-title":"Impact of [11C]methionine positron emission tomography for target definition of glioblastoma multiforme in radiation therapy planning","volume":"82","author":"Matsuo","year":"2012","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2024.104552_bib58","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/407026","article-title":"Hypofractionated high-dose irradiation with positron emission tomography data for the treatment of glioblastoma multiforme","volume":"2014","author":"Miwa","year":"2014","journal-title":"Biomed. Res Int"},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104552_bib59","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/028418518903000301","article-title":"Positron emission tomography compared with magnetic resonance imaging and computed tomography in supratentorial gliomas using multiple stereotactic biopsies as reference","volume":"30","author":"Mosskin","year":"1989","journal-title":"Acta Radio."},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104552_bib60","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/neuonc\/nou316","article-title":"Impact of [18F]-fluoro-ethyl-tyrosine PET imaging on target definition for radiation therapy of high-grade glioma","volume":"17","author":"Munck Af Rosenschold","year":"2015","journal-title":"Neuro-Oncol."},{"key":"10.1016\/j.critrevonc.2024.104552_bib61","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.radonc.2018.10.003","article-title":"Influence of volumetric modulated arc therapy and FET-PET scanning on treatment outcomes for glioblastoma patients","volume":"130","author":"Munck Af Rosenschold","year":"2019","journal-title":"Radio. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104552_bib62","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/00004647-199706000-00007","article-title":"Analysis of [C-11]alpha-methyl-tryptophan kinetics for the estimation of serotonin synthesis rate in vivo","volume":"17","author":"Muzik","year":"1997","journal-title":"J. Cereb. Blood Flow. Metab."},{"issue":"40","key":"10.1016\/j.critrevonc.2024.104552_bib63","doi-asserted-by":"crossref","first-page":"67696","DOI":"10.18632\/oncotarget.18809","article-title":"Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study","volume":"8","author":"Navarria","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104552_bib64","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.radonc.2014.09.004","article-title":"Investigation on the role of integrated PET\/MRI for target volume definition and radiotherapy planning in patients with high grade glioma","volume":"112","author":"Navarria","year":"2014","journal-title":"Radio. Oncol."},{"key":"10.1016\/j.critrevonc.2024.104552_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109663","article-title":"ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma","volume":"184","author":"Niyazi","year":"2023","journal-title":"Radio. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104552_bib66","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11060-021-03844-1","article-title":"18)F-FET-PET-guided gross total resection improves overall survival in patients with WHO grade III\/IV glioma: moving towards a multimodal imaging-guided resection","volume":"155","author":"Ort","year":"2021","journal-title":"J. Neurooncol"},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104552_bib67","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/jcbfm.1988.69","article-title":"Assessment of [11C]-L-methionine transL-port into the human brain","volume":"8","author":"O'Tuama","year":"1988","journal-title":"J. Cereb. Blood Flow. Metab."},{"issue":"8","key":"10.1016\/j.critrevonc.2024.104552_bib68","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/neuonc\/not002","article-title":"Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study","volume":"15","author":"Pafundi","year":"2013","journal-title":"Neuro Oncol."},{"issue":"Pt 3","key":"10.1016\/j.critrevonc.2024.104552_bib69","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/brain\/awh399","article-title":"O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas","volume":"128","author":"Pauleit","year":"2005","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104552_bib70","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00066-011-0060-5","article-title":"Integrated boost IMRT with FET-PET-adapted local dose escalation in glioblastomas. results of a prospective phase II study","volume":"188","author":"Piroth","year":"2012","journal-title":"Strahl. Onkol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104552_bib71","article-title":"A systematic review of amino acid PET in assessing treatment response to temozolomide in glioma","volume":"4","author":"Prather","year":"2022","journal-title":"Neurooncol. Adv."},{"key":"10.1016\/j.critrevonc.2024.104552_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109768","article-title":"Dosimetric patterns of failure in the era of novel chemoradiotherapy in newly-diagnosed glioblastoma patients","volume":"188","author":"Seaberg","year":"2023","journal-title":"Radio. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104552_bib73","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1158\/1078-0432.CCR-20-1775","article-title":"Final Results of the Prospective Biomarker Trial PETra: [11C]-MET-Accumulation in Postoperative PET\/MRI Predicts Outcome after Radiochemotherapy in Glioblastoma","volume":"27","author":"Seidlitz","year":"2021","journal-title":"Clin. Cancer Res"},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104552_bib74","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1007\/s00259-019-04656-2","article-title":"Simultaneous FET-PET and contrast-enhanced MRI based on hybrid PET\/MR improves delineation of tumor spatial biodistribution in gliomas: a biopsy validation study","volume":"47","author":"Song","year":"2020","journal-title":"Eur. J. Nucl. Med Mol. Imaging"},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104552_bib75","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1007\/s00330-020-07470-9","article-title":"Static (18)F-FET PET and DSC-PWI based on hybrid PET\/MR for the prediction of gliomas defined by IDH and 1p\/19q status","volume":"31","author":"Song","year":"2021","journal-title":"Eur. Radio."},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104552_bib76","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol."},{"issue":"10","key":"10.1016\/j.critrevonc.2024.104552_bib77","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med"},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104552_bib78","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s12149-013-0792-7","article-title":"O-(2-[(18)F]fluoroethyl)-L-tyrosine uptake is an independent prognostic determinant in patients with glioma referred for radiation therapy","volume":"28","author":"Sweeney","year":"2014","journal-title":"Ann. Nucl. Med"},{"issue":"12","key":"10.1016\/j.critrevonc.2024.104552_bib79","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1023\/A:1026654116999","article-title":"A. Brain net unidirectional uptake of alpha-[14c]methyl-L-tryptophan (alpha-MTrp) and its correlation with regional serotonin synthesis, tryptophan incorporation into proteins, and permeability surface area products of tryptophan and alpha-MTrp","volume":"25","author":"Tohyama","year":"2000","journal-title":"Neurochem Res"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104552_bib80","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13550-017-0295-y","article-title":"Towards standardization of (18)F-FET PET imaging: do we need a consistent method of background activity assessment?","volume":"7","author":"Unterrainer","year":"2017","journal-title":"EJNMMI Res"},{"issue":"13","key":"10.1016\/j.critrevonc.2024.104552_bib81","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1007\/s00259-021-05530-w","article-title":"Dynamic amino-acid PET in neuro-oncology: a prognostic tool becomes essential","volume":"48","author":"Verger","year":"2021","journal-title":"Eur. J. Nucl. Med Mol. Imaging"},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104552_bib82","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00259-017-3846-6","article-title":"Static and dynamic (18)F-FET PET for the characterization of gliomas defined by IDH and 1p\/19q status","volume":"45","author":"Verger","year":"2018","journal-title":"Eur. J. Nucl. Med Mol. Imaging"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104552_bib83","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13550-018-0444-y","article-title":"Voxel-wise analysis of dynamic (18)F-FET PET: a novel approach for non-invasive glioma characterisation","volume":"8","author":"Vomacka","year":"2018","journal-title":"EJNMMI Res"},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104552_bib84","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s002590050541","article-title":"O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study","volume":"27","author":"Weber","year":"2000","journal-title":"Eur. J. Nucl. Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104552_bib85","first-page":"205","article-title":"Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging","volume":"40","author":"Wester","year":"1999","journal-title":"J. Nucl. Med"},{"issue":"8","key":"10.1016\/j.critrevonc.2024.104552_bib86","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann. Intern Med"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842824002956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842824002956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T03:22:53Z","timestamp":1734405773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842824002956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":86,"alternative-id":["S1040842824002956"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104552","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of amino acid PET in radiotherapy target volume delineation for adult-type diffuse gliomas: A review of the literature","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104552","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104552"}}